Indivior Pharmaceuticals (INDV) Property, Plant & Equipment (Net) (2021 - 2026)
Indivior Pharmaceuticals (INDV) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 2.96 Bn |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn | 162.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 162.00 Mn |
| Jun 30, 2026 | 162.00 Mn |
| Mar 31, 2026 | 157.00 Mn |
| Mar 31, 2026 | 157.00 Mn |
| Dec 31, 2025 | 144.00 Mn |
| Dec 31, 2025 | 144.00 Mn |
| Sep 30, 2025 | 124.00 Mn |
| Sep 30, 2025 | 124.00 Mn |
| Jun 30, 2025 | 117.00 Mn |
| Jun 30, 2025 | 117.00 Mn |
| Mar 31, 2025 | 104.00 Mn |
| Mar 31, 2025 | 104.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Dec 31, 2022 | 54.00 Mn |
| Dec 31, 2022 | 54.00 Mn |
| Dec 31, 2021 | 388.00 Mn |
| Dec 31, 2021 | 388.00 Mn |